Operative Management in Stage IV Breast Cancer.
Surg Clin North Am
; 103(1): 93-106, 2023 Feb.
Article
en En
| MEDLINE
| ID: mdl-36410356
ABSTRACT
Traditionally, surgical therapy for primary breast lesions in stage IV breast cancer has been reserved for palliation. Several retrospective studies have suggested a possible survival benefit with surgical resection of the primary tumor in patients with distant metastases. However, evidence from prospective, randomized controlled trials suggest that locoregional control provides no clear survival advantage for patients with stage IV breast cancer. Future areas of inquiry include identification of subsets of patients who may derive a survival benefit from locoregional control.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
Límite:
Female
/
Humans
Idioma:
En
Revista:
Surg Clin North Am
Año:
2023
Tipo del documento:
Article